Mosaic ImmunoEngineering (CPMV) Research & Development (2010 - 2026)
Mosaic ImmunoEngineering (CPMV) recorded Research & Development of $15,880 in Q1 2026, up 0.5% from $15,803 a year earlier but down 1.6% from the prior quarter.
Mosaic ImmunoEngineering (CPMV) Research & Development (2010 - 2026) Analysis & Trends
On a TTM basis, Mosaic ImmunoEngineering's Research & Development came in at $64,058 as of Mar 31, 2026, down 51.6% year-over-year; for FY2025, it came in at $63,981, down 65.2% from FY2024.
- Annual Research & Development has declined for four straight years, with a five-year compound annual growth rate of -28.5% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $183,867 in FY2024 (-57.8%), $435,449 in FY2023 (-58.5%), $1.05 million in FY2022 (-28.0%) and $1.46 million in FY2021 (+324.9%).
- Quarterly Research & Development has ranged from $15,803 in Q1 2025 to $439,926 in Q3 2021 over the past five years.
- On a year-over-year basis, Research & Development rose in 1 of the last eight quarters, with an average decline of 47.7%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 33.1% in Q1 2022, against a decline of 76.5% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $16,133 (Q4 2025), $16,039 (Q3 2025) and $16,006 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Mosaic ImmunoEngineering | 434,528.21 | 434,528.21 | - | 15,880.00 |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15,880.00 |
| Dec 31, 2025 | 16,133.00 |
| Sep 30, 2025 | 16,039.00 |
| Jun 30, 2025 | 16,006.00 |
| Mar 31, 2025 | 15,803.00 |
| Dec 31, 2024 | 16,250.00 |
| Sep 30, 2024 | 39,599.00 |
| Jun 30, 2024 | 60,707.00 |
| Mar 31, 2024 | 67,311.00 |
| Dec 31, 2023 | 49,989.00 |
| Sep 30, 2023 | 84,927.00 |
| Jun 30, 2023 | 122,638.00 |
| Mar 31, 2023 | 177,895.00 |
| Dec 31, 2022 | 207,022.00 |
| Sep 30, 2022 | 211,082.00 |
| Jun 30, 2022 | 302,694.00 |
| Mar 31, 2022 | 327,659.00 |
| Dec 31, 2021 | 393,278.00 |
| Sep 30, 2021 | 439,926.00 |
| Jun 30, 2021 | 376,767.00 |
Mosaic ImmunoEngineering Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CPMV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CPMV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CPMV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();